Bayer Aktiengesellschaft (BAYRY) News Today $7.98 -0.14 (-1.72%) As of 07/11/2025 03:58 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesInsider TradesSEC FilingsShort InterestBuy This Stock Why Is Bayer Aktiengesellschaft Down Today?Toggle Visibility of Why Is Bayer Aktiengesellschaft Down Today?Bayer Aktiengesellschaft (BAYRY) shares have seen mixed trading today, supported by new product launches, regulatory approvals and bullish analyst recognition, while a recent rating downgrade weighed on sentiment. Positive Sentiment: Bayer has introduced a new fungicide targeting sheath blight in paddy, expanding its crop‐protection portfolio in a key agricultural market. Bayer launches new fungicide to control sheath blight in paddy Positive Sentiment: The UK granted Bayer the first global approval for Lynkuet, a hormone‐free treatment for menopause‐related hot flashes, marking a significant regulatory milestone. Bayer scores first approval for hormone-free menopause drug Lynkuet in UK Positive Sentiment: An experimental Bayer therapy has shown promise in easing menopause‐like symptoms induced by breast cancer treatment, underscoring the company’s R&D strength in women’s health. Health Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapy Positive Sentiment: Bayer was featured on Zacks’ list of Best Value Stocks to Buy for July 10th, earning a Zacks Rank #1 (Strong Buy) designation. Best Value Stocks to Buy for July 10th Neutral Sentiment: To commemorate 125 years of operations in Italy, Bayer issued a special stamp, highlighting its long‐standing heritage but with limited direct financial impact. 125 Years of Bayer in Italy: A Stamp to Celebrate the Past and Build the Future Negative Sentiment: Wall Street Zen downgraded Bayer from a “buy” rating to “hold,” potentially tempering investor enthusiasm. Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Rating Lowered to "Hold" at Wall Street Zen Posted 18h agoAI Generated. May Contain Errors. BAYRY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period 🚨 Bayer Leverkusen sign Malik Tillman4 hours ago | sports.yahoo.comOfficial | Bayer Leverkusen complete the signing of Malik Tillman from PSV Eindhoven for €35m4 hours ago | sports.yahoo.comBayer Leverkusen signs US midfielder Malik Tillman for club-record fee4 hours ago | msn.comBayer Leverkusen hold concrete talks for PSV winger Johan BakayokoJuly 11 at 8:06 PM | sports.yahoo.comCould Bayer Leverkusen’s Granit Xhaka be heading to Saudi Arabia?July 11 at 8:06 PM | sports.yahoo.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Rating Lowered to "Hold" at Wall Street ZenJuly 11 at 2:35 AM | marketbeat.comBayer Leverkusen rival Premier League teams for PSV wingerJuly 10 at 6:55 PM | sports.yahoo.comHealth Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapyJuly 10 at 6:55 PM | msn.comBayer Leverkusen reach £5M agreement for Manchester City forward – Details for sell-on clause revealedJuly 10 at 6:55 PM | sports.yahoo.comBayer Leverkusen looking for a creative difference maker and a left footed right winger as they continue refreshJuly 9 at 10:43 PM | sports.yahoo.comBayer’s Observational Study on Eylea in Preterm Infants: Market ImplicationsJuly 9 at 12:16 PM | tipranks.comHealth Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapyJuly 9 at 7:07 AM | reuters.comVictor Boniface’s future at Bayer Leverkusen to be decided over pre-seasonJuly 8, 2025 | sports.yahoo.comFlorian Wirtz first conversation after Bayer Leverkusen transfer shows Liverpool star’s true determinationJuly 8, 2025 | msn.comBayer Leverkusen place an €8-15 million valuation on Juventus target Granit XhakaJuly 8, 2025 | ca.sports.yahoo.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Rating Lowered to Hold at Wall Street ZenJuly 6, 2025 | americanbankingnews.comBAYRY - Bayer AG ADR Sustainability - MorningstarJuly 5, 2025 | morningstar.comMPSV to sign Bayer Leverkusen’s Matěj KovářJuly 5, 2025 | sports.yahoo.comWhat Makes Bayer (BAYRY) a New Buy Stock - NasdaqJuly 5, 2025 | nasdaq.comBayer (0P6S) Receives a Buy from Goldman SachsJuly 5, 2025 | theglobeandmail.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Stock Rating Lowered by Wall Street ZenJuly 5, 2025 | marketbeat.comAlbacete threaten Bayer Leverkusen target Christian Kofane with legal actionJuly 4, 2025 | ca.sports.yahoo.comFrom Bayer Leverkusen to FC Red Bull SalzburgJuly 4, 2025 | sports.yahoo.comBayer Leverkusen could pursue Monaco’s Maghnes Akliouche this summer if no other clubs doJuly 4, 2025 | sports.yahoo.comBayer’s Promising Parkinson’s Study: AAV2-GDNF Gene Therapy in FocusJuly 3, 2025 | tipranks.comErik ten Hag risks wrath of Bayer Leverkusen fans with message to Jarell QuansahJuly 2, 2025 | mirror.co.ukMBayer Leverkusen complete signing of Liverpool defender Jarell QuansahJuly 2, 2025 | nytimes.comBayer Leverkusen’s Simon Rolfes: “Our goal is to use the transfer fee for Florian to build the next title-winning team”July 2, 2025 | sports.yahoo.comLiverpool defender Quansah signs for Bayer LeverkusenJuly 2, 2025 | msn.comLongtime Bayer executive takes helm of North American finance operationsJuly 1, 2025 | bizjournals.comBAYRY - Bayer AG ADR Price vs Fair Value | MorningstarJuly 1, 2025 | morningstar.comMBayer AG’s Real-World Study on Vericiguat: Implications for Heart Failure Treatment in JapanJuly 1, 2025 | tipranks.comBayer Leverkusen unveil new 2025/26 home kitJuly 1, 2025 | sports.yahoo.com🚨 Reports: Bayer find Wirtz’s replacement, set to fill star’s bootsJuly 1, 2025 | sports.yahoo.comReal Madrid rule out signing of €27m-rated Bayer Leverkusen star – reportJuly 1, 2025 | sports.yahoo.comU.S. Supreme Court seeks federal input on Bayer's Roundup caseJune 30, 2025 | msn.comBayer Aktiengesellschaft (OTCMKTS:BAYRY) Shares Down 4.1% - Here's What HappenedJune 30, 2025 | marketbeat.comUS Supreme Court seeks Justice Department views on Bayer's Roundup appealJune 30, 2025 | reuters.comBayer says U.S. Supreme Court asks solicitor general for opinion in glyphosate caseJune 30, 2025 | reuters.comBayer Leverkusen prepare €30m offer for Justin KluivertJune 29, 2025 | sports.yahoo.comJarell Quansah’s Bayer Leverkusen medical set for MondayJune 28, 2025 | sports.yahoo.comCourt Approves $38M Cash Settlement Against Bayer AG in Hard-Fought Securities Class ActionJune 27, 2025 | globenewswire.comBayer AG’s Observational Study on Liver Cancer Treatment: Key Insights for InvestorsJune 27, 2025 | tipranks.comBayer’s Promising DVT Treatment Study: Key Insights for InvestorsJune 26, 2025 | tipranks.comWall Street Zen Upgrades Bayer Aktiengesellschaft (OTCMKTS:BAYRY) to "Buy"June 26, 2025 | marketbeat.comXhaka’s father confirms Milan talks as Bayer set new conditionsJune 25, 2025 | sports.yahoo.comEY US & Bayer Win “Artificial Intelligence for Good” Award in 2025 AI Breakthrough Awards ProgramJune 25, 2025 | globenewswire.comBayer’s Molidustat Study: A Potential Game-Changer in Renal Anemia TreatmentJune 24, 2025 | tipranks.comLiverpool confirm Florian Wirtz signing from Bayer LeverkusenJune 21, 2025 | nytimes.comLiverpool signs Florian Wirtz from Bayer Leverkusen for huge fee that could climb to $156 millionJune 21, 2025 | msn.com Get Bayer Aktiengesellschaft News Delivered to You Automatically Sign up to receive the latest news and ratings for BAYRY and its competitors with MarketBeat's FREE daily newsletter. Email Address BAYRY Media Mentions By Week BAYRY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BAYRY News Sentiment▼0.241.00▲Average Medical News Sentiment BAYRY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BAYRY Articles This Week▼178▲BAYRY Articles Average Week Get Bayer Aktiengesellschaft News Delivered to You Automatically Sign up to receive the latest news and ratings for BAYRY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sanofi News Today Innoviva News Today Eli Lilly and Company News Today Johnson & Johnson News Today AbbVie News Today Novo Nordisk A/S News Today Roche News Today Novartis News Today Merck & Co., Inc. News Today Pfizer News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BAYRY) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bayer Aktiengesellschaft Please log in to your account or sign up in order to add this asset to your watchlist. Share Bayer Aktiengesellschaft With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
